HEFFLER, Enrico Marco
 Distribuzione geografica
Continente #
NA - Nord America 11.120
AS - Asia 7.724
EU - Europa 2.652
SA - Sud America 1.663
AF - Africa 415
OC - Oceania 49
Continente sconosciuto - Info sul continente non disponibili 10
AN - Antartide 1
Totale 23.634
Nazione #
US - Stati Uniti d'America 10.823
SG - Singapore 4.749
BR - Brasile 1.372
CN - Cina 1.089
VN - Vietnam 755
DE - Germania 448
IT - Italia 424
FI - Finlandia 407
IE - Irlanda 318
NG - Nigeria 263
HK - Hong Kong 254
FR - Francia 213
IN - India 180
GB - Regno Unito 172
NL - Olanda 153
CA - Canada 151
AR - Argentina 114
MX - Messico 98
BD - Bangladesh 93
SE - Svezia 89
RU - Federazione Russa 78
TR - Turchia 75
ID - Indonesia 63
IQ - Iraq 59
ZA - Sudafrica 53
TW - Taiwan 50
EC - Ecuador 49
JP - Giappone 47
KR - Corea 45
ES - Italia 44
BE - Belgio 43
AU - Australia 42
CZ - Repubblica Ceca 41
PK - Pakistan 38
PL - Polonia 37
CO - Colombia 34
UA - Ucraina 33
VE - Venezuela 31
MY - Malesia 29
CH - Svizzera 28
IL - Israele 26
CL - Cile 24
AT - Austria 22
JO - Giordania 22
MA - Marocco 22
SA - Arabia Saudita 22
PY - Paraguay 17
UZ - Uzbekistan 16
DZ - Algeria 15
EG - Egitto 15
RO - Romania 15
AE - Emirati Arabi Uniti 12
AZ - Azerbaigian 12
KE - Kenya 12
PH - Filippine 12
NP - Nepal 11
LT - Lituania 10
PE - Perù 10
TN - Tunisia 10
UY - Uruguay 10
AL - Albania 9
PT - Portogallo 9
IR - Iran 8
JM - Giamaica 8
TH - Thailandia 8
KZ - Kazakistan 7
NO - Norvegia 7
SN - Senegal 7
CR - Costa Rica 6
DK - Danimarca 6
ET - Etiopia 6
HR - Croazia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BA - Bosnia-Erzegovina 5
BG - Bulgaria 5
GR - Grecia 5
GT - Guatemala 5
KG - Kirghizistan 5
LB - Libano 5
NZ - Nuova Zelanda 5
OM - Oman 5
PA - Panama 5
TT - Trinidad e Tobago 5
DO - Repubblica Dominicana 4
HU - Ungheria 4
LV - Lettonia 4
MD - Moldavia 4
NI - Nicaragua 4
PS - Palestinian Territory 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
AM - Armenia 3
BB - Barbados 3
BH - Bahrain 3
CI - Costa d'Avorio 3
GM - Gambi 3
SV - El Salvador 3
XK - ???statistics.table.value.countryCode.XK??? 3
CY - Cipro 2
EU - Europa 2
Totale 23.598
Città #
Singapore 1.968
Chandler 1.322
Wilmington 1.289
Dallas 819
The Dalles 732
Ashburn 705
San Jose 547
San Mateo 482
Shanghai 452
Ann Arbor 416
Helsinki 402
Dublin 297
Ho Chi Minh City 270
Boardman 260
Benin City 259
New York 251
Lawrence 234
Princeton 234
Hong Kong 221
Leawood 221
Beijing 217
Hanoi 166
Los Angeles 147
Santa Clara 134
São Paulo 126
Fairfield 125
Falkenstein 125
Paris 124
Woodbridge 107
Amsterdam 106
Toronto 74
London 67
Buffalo 65
Milan 61
Seattle 53
Orem 45
Council Bluffs 40
Munich 40
Rio de Janeiro 40
Haiphong 37
Belo Horizonte 36
Da Nang 36
San Diego 35
Redwood City 34
Brussels 32
Columbus 32
Mexico City 31
Kocaeli 30
Naples 30
Norwalk 30
Pune 29
Menlo Park 28
Phoenix 28
Warsaw 28
Curitiba 24
Frankfurt am Main 24
Tokyo 24
Johannesburg 23
Boston 22
Brasília 22
Campinas 22
Baghdad 21
Chennai 21
Monmouth Junction 21
Mumbai 21
Newark 21
Brno 20
Chicago 20
Houston 20
San Francisco 20
Stockholm 20
Brooklyn 19
Guayaquil 19
Montreal 19
Amman 18
Charlotte 18
Jakarta 18
Porto Alegre 17
Salvador 17
Atlanta 16
Rome 16
Denver 15
Falls Church 15
Philadelphia 15
Can Tho 14
Dongguan 14
Hyderabad 14
Nuremberg 14
Goiânia 13
Guarulhos 13
Quito 13
Des Moines 12
Dhaka 12
Hillsboro 12
Hải Dương 12
Reston 12
Tashkent 12
Thái Bình 12
Asunción 11
Melbourne 11
Totale 14.508
Nome #
The 10th anniversary of the Junior Members and Affiliates of the European Academy of Allergy and Clinical Immunology. 757
Multi-strain Symbiotic Preparations as a Novel Adjuvant Approach to Allergic Rhinitis 379
Probiotics as a Novel Adjuvant Approach to Atopic Dermatitis 303
Olfactory impairment in Italian patients with chronic rhinosinusitis with nasal polyps: a patient-centered survey 192
NAPPREB study protocol: A pivotal clinical trial to investigate clinical efficacy and potential response biomarkers to Benralizumab treatment in chronic rhinosinusitis with nasal polyps 163
"Characteristics of patients admitted to emergency department for asthma attack: a real-LIFE study". 155
A critical appraisal on AIT in childhood asthma. 153
Research needs in allergy: an EAACI position paper, in collaboration with EFA 136
Very rapid improvement of extended nitric oxide parameters, associated with clinical and functional betterment, in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) treated with Dupilumab 133
Multiple Drug Allergy Due to Hypersensitivity to Polyethylene Glycols of Various Molecular Weights 129
Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry 129
Nasal Polyposis Quality of Life (NPQ): Development and Validation of the First Specific Quality of Life Questionnaire for Chronic Rhinosinusitis with Nasal Polyps 128
Omalizumab for Idiopathic Nonhistaminergic Angioedema: Evidence for Efficacy in 2 Patients. 127
Macrogol hypersensitivity reactions during cleansing preparation for colon endoscopy. 125
Italian study on buckwheat allergy: prevalence and clinical features of buckwheat-sensitized patients in Italy 119
Allergy clinics in times of the SARS-CoV-2 pandemic: an integrated model 119
Allergic patients during the COVID-19 pandemic-Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey 118
Hypersensitivity to gelatin used as excipient for soft capsules of Ibuprofen 118
The accuracy of the HemoCue WBC DIFF in assessing blood eosinophils depends on the clinical setting and medical condition 117
An academic allergy unit during COVID-19 pandemic in Italy. 116
Allergic sensitization to common pets (cats/dogs) according to different possible modalities of exposure: an Italian Multicenter Study. 116
Adherence issues related to sublingual immunotherapy as perceived by allergists. 114
A Bloody Mess: An Unusual Case of Diffuse Alveolar Hemorrhage Because of Warfarin Overdose 114
Exhaled nitric oxide measurements: correction equation to compare hand-held device to stationary analyzer 113
Allergy in severe asthma. 113
A prevalent exposure to male dog is a risk factor for exclusive allergic sensitization to Can f 5: An Italian Multicenter Study. 113
Acute urticaria presenting in the emergency room of a general hospital 112
Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper. 112
Nasal nitric oxide concentration in suspected chronic rhinosinusitis 108
Allergy in internet 105
Pertinence of requested allergy consultations for suspected food allergy/intolerance. A Junior Members working group of Italian Society of Allergy and Clinical Immunology (SIAIC) multicenter study. 103
Immunological mechanisms underlying chronic rhinosinusitis with nasal polyps 102
Acute asthma management during SARS-CoV2-pandemic 2020 102
Aligning the Good Practice MASK With the Objectives of the European Innovation Partnership on Active and Healthy Ageing 100
Incidence of food anaphylaxis in Piemonte region (Italy): data from registry of Center for Severe Allergic Reactions. 99
The Severe Asthma Network in Italy: Findings and Perspectives 98
Allergy to buckwheat: an emerging clinical problem. Clinical and laboratory analysis of 24 consecutive patients 98
Treatable traits in chronic rhinosinusitis with nasal polyps 97
Allergen immunotherapy for respiratory allergy: Quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool. An EAACI methodology committee analysis 97
Level of exhaled nitric oxide during human anaphylaxis 95
Evolving phenotypes to endotypes: is precision medicine achievable in asthma? 94
Nasal cytology: Methodology with application to clinical practice and research. 94
Allergen immunotherapy and biologics in respiratory allergy: friends or foes? 94
Asthma from immune pathogenesis to precision medicine 93
Clinical presentation at the onset of COVID-19 and allergic rhinoconjunctivitis 93
Breath analysis in patients with end-stage renal disease: effect of haemodialysis 92
Unexpected visitor: “hidden” food allergens 91
Reduction of oral corticosteroids in patients with severe eosinophilic asthma treated with Benralizumab: could it represent a marker of treatment efficacy? 90
Exhaled nitric oxide in asthma. 88
Pharmacokinetics and pharmacodynamics of monoclonal antibodies for asthma treatment 88
Unexplained chronic cough and vitamin B-12 deficiency. 88
Strategies to reduce corticosteroid-related adverse events in asthma 88
Anaphylaxis after eating italian pizza containing buckwheat as the hidden allergen 87
Oxidative stress and airway inflammation after allergen challenge evaluated by exhaled breath condensate analysis 87
Exhaled nitric oxide as a clinical biomarker for choosing biologics for severe asthma treatment. 87
Anaphylaxis after a horse bite 87
Type 2 Inflammation in Eosinophilic Esophagitis: From Pathophysiology to Therapeutic Targets 86
Effect of an educational intervention delivered by pharmacists on adherence to treatment, disease control and lung function in patients with asthma 86
Prevalence of over-/misdiagnosis of asthma in patients referred to an allergy clinic. 85
Eosinophils Target Therapy for Severe Asthma: Critical Points 85
Microarray Immunodiagnostics for Aeroallergens 84
Appropriateness in allergic respiratory diseases health care in Italy: definitions and organizational aspects 84
One year of mepolizumab. Efficacy and safety in real-life in Italy 84
Pharmacoeconomic evaluation of oral corticosteroid adverse events in patients with severe asthma 84
Allergen immunotherapy: The growing role of observational and randomized trial "Real-World Evidence" 84
Alpha1-antitrypsin deficiency and asthma 84
The Patient-Centered Decision System as per the 4Ps of Precision Medicine 83
New drugs in early-stage clinical trials for allergic rhinitis 81
Interleukin-5 in the Pathophysiology of Severe Asthma 81
EAACI consensus statement for investigation of work-related asthma in non-specialized centres 81
Extended nitric oxide analysis in patients with chronic rhinosinusitis with nasal polyps, with or without associated asthma 81
Bronchodilator response as a marker of poor asthma control 79
Is air pollution affecting the disease activity in patients with systemic lupus erythematosus? State of the art and a systematic literature review. 79
Diagnostic classification of persistent rhinitis and its relationship to exhaled nitric oxide and asthma: a clinical study of a consecutive series of patients. 79
Real-life studies of biologics used in asthma patients: key differences and similarities to trials 79
Validation of the Italian version of the Test of Adherence to Inhalers (TAI) 79
Gene Environment Interactions in Respiratory Diseases – Protocol, Standard Operative Procedures and Questionnaires 79
Minimal clinically important difference for asthma endpoints: an expert consensus report 79
Advancing Precision Medicine in Asthma: Evolution of Treatment Outcomes 78
Escaping the trap of allergic rhinitis. 78
Long-lasting clinical, radiological and immunological remission of severe nasal polyposis by means of 'reboot' surgery. 78
Warning nonrespiratory symptoms in asthma: catastrophic abdominal involvement in a case of Churg-Strauss syndrome 78
Clinical manifestations, co-sensitizations, and immunoblotting profiles of buckwheat-allergic patients. 78
Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets 77
Determinants of exhaled nitric oxide in chronic rhinosinusitis 77
Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center 76
Exhaled nitric oxide's ability to predict methacholine challenge: a matter of definition 76
Exhaled breath condensate pH and cysteinyl leukotriens in patients with chronic cough secondary to acid gastroesophageal reflux 76
Nasal nitric oxide in patients with inherited retinal dystrophies. 75
Epinephrine autoinjector prescription in food-allergic adults: symptom-based only or allergen-based also? An Italian multi-centre study 75
Kounis syndrome: Aspects on pathophysiology and management 75
Validation and Qualification of Biomarkers and Their Translation Into Pathway-Specific Diagnostic Tests 74
Exhaled nitric oxide in persistent rhinitis with or without lower airway involvement: a review of the literature. 74
Airways Type-2 Related Disorders: Multiorgan, Systemic or Syndemic Disease? 73
Do the current guidelines for asthma pharmacotherapy encourage over-treatment? 73
Alveolar concentration and bronchial output of exhaled nitric oxide in chronic rhinosinusitis 73
Misdiagnosis of asthma and COPD and underuse of spirometry in primary care unselected patients 73
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 73
Community pharmacist's professional adaptation amid Covid-19 emergency: a national survey on Italian pharmacists 73
Adult Severe Asthma Registries: A Global and Growing Inventory 72
Totale 10.729
Categoria #
all - tutte 144.469
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 144.469


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021241 0 0 0 0 0 0 0 0 0 0 0 241
2021/20221.422 62 37 51 298 22 30 52 190 117 110 380 73
2022/20233.681 550 149 348 416 354 295 26 290 657 297 234 65
2023/20242.110 183 242 437 66 114 184 90 136 63 60 176 359
2024/20254.141 128 105 78 106 156 385 229 392 643 925 467 527
2025/20269.879 1.378 623 992 1.086 317 388 2.606 669 554 584 451 231
Totale 23.889